Home » Newsletters » BioWorld Science

BioWorld Science

July 15, 1998

View Archived Issues

Antipsychotic drug trifluoperazine inhibits growth of mycobacterial isolates

Potent, broad-spectrum cephalosporin antibiotics in the pipeline at Roche

Fast track designation granted for FGN-1 in APC

Abbott completes acquisition of Murex

FDA requests additional analysis of Exelon before U.S. approval

Mylan announces copromotion agreement

INVICORP approved for launch in Denmark

NeXstar initiates second part of MiKasome phase II trial and reports preliminary findings

Italian launch for Prograf announced

Cyclacel licenses novel drug delivery technology from CNRS

Lilly describes serotonergic agents for treating obesity, CNS disorders

Centrally acting muscarinic agents discovered at American Home Products

Neurocrine Biosciences takes over clinical development of benzodiazepine

World's first brain cell transplant performed in stroke patient

TSL-225, a dipeptide inhibitor of dipeptidyl peptidase IV

CR-2945, a promising new anxiolytic agent in preclinical testing

NIH finds new selective ligands for studying P2X1 purinoceptors

New semisynthetic macrolide antibiotics designed by Pliva

Mitsui Toatsu describes potent, long-acting and orally bioavailable antipsychotic agents

Indolocarbazoles for prostate disorders jointly developed by Cephalon and Kyowa Hakko

Preliminary evidence of antidepressant effect for igmesine, a sigma ligand

Company Profile: Amur

ID Biomedical and Mitsubishi Chemical sign distribution agreement

M-100907 improves positive and negative symptoms and is well tolerated in schizophrenics

Clinical evaluation of AlloMune transplantation system begins

Orally active gastric antisecretory agents synthesized and evaluated at Daiichi

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...